Cantai Therapeutics, Inc.
Biotechnology company · Philadelpia, Pennsylvania, United States
Cantai Therapeutics, Inc. is a biotechnology company headquartered in Philadelpia, Pennsylvania, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2026.
Cantai Therapeutics at a glance
What does Cantai Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3 million sold (2026).
Frequently asked questions about Cantai Therapeutics
Where is Cantai Therapeutics headquartered?
Cantai Therapeutics, Inc. is headquartered in Philadelpia, Pennsylvania, United States.
What does Cantai Therapeutics do?
Cantai Therapeutics, Inc. is a biotechnology company.
When was Cantai Therapeutics founded?
The earliest incorporation on record for Cantai Therapeutics, Inc. is in 2023, according to public company registers.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
- Passage BIO, Inc.Philadelphia, Pennsylvania, United States
- ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
- Enterin, Inc.Philadelphia, Pennsylvania, United States
- Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences